Ginkgo Bioworks Holdings Inc (DNA) PT Lowered to $7 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs analyst Matthew Sykes lowered the price target on Ginkgo Bioworks Holdings Inc (NYSE: DNA) to $7.00 (from $12.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
